Related categories
Siblings:
15 found
Search inside:
(import / add options)   Sort by:
  1. Fatima Agha Al-Hayani (2007). Biomedical Ethics: Muslim Perspectives on Genetic Modification. Zygon 42 (1):153-162.
    Technology pertaining to genetically modified foods has created an abundance of food and various methods to protect new products and enhance productivity. However, many scientists, economists, and humanitarians have been critical of the application of these discoveries. They are apprehensive about a profit-driven mentality that, to them, seems to propel the innovators rather than a poverty-elimination mentality that should be behind such innovations. The objectives should be to afford the most benefit to those in need and to prevent hunger around (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  2. Colin Farrelly (2007). Virtue Ethics and Prenatal Genetic Enhancement. Studies in Ethics, Law, and Technology 1 (1).
    In this paper I argue that the virtue ethics tradition can enhance the moral discourse on the ethics of prenatal genetic enhancements in distinctive and valuable ways. Virtue ethics prescribes we adopt a much more provisional stance on the issue of the moral permissibility of prenatal genetic enhancements. A stance that places great care on differentiating between the different stakes involved with developing different phenotypes in our children and the different possible means (environmental vs. genetic manipulation) available to parents for (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  3. Michiel Korthals & Cristian Timmermann (2012). Reflections on the International Networking Conference “Ethical and Social Aspects of Intellectual Property Rights – Agrifood and Health” Brussels, September 2011. Synesis 3:G66-73.
    Public goods, as well as commercial commodities, are affected by exclusive arrangements secured by intellectual property (IP) rights. These rights serve as an incentive to invest human and material capital in research and development. Particularly in the life sciences, IP rights regulate objects such as food and medicines that are key to securing human rights, especially the right to adequate food and the right to health. Consequently, IP serves private (economic) and public interests. Part of this charge claims that the (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  4. Matthew Lister (2007). Well-Ordered Science. Journal of Philosophical Research 32:127-139.
    The debate over the use of genetically-modified (GM) crops is one where the heat to light ratio is often quite low. Both proponents and opponents of GM crops often resort more to rhetoric than argument. This paper attempts to use Philip Kitcher’s idea of a “well-ordered science” to bring coherence to the debate. While I cannot, of course, here decide when and where, if at all, GM crops should be used I do show how Kitcher’s approach provides a useful framework (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  5. Michele Loi (2012). Germ-Line Enhancements and Rough Equality. Ethical Perspectives 19 (1):55-82.
    Enhancements of the human germ-line introduce further inequalities in the competition for scarce goods, such as income and desirable social positions. Social inequalities, in turn, amplify the range of genetic inequalities that access to germ-line enhancements may produce. From an egalitarian point of view, inequalities can be arranged to the benefit of the worst-off group (for instance, through general taxation), but the possibility of an indefinite growth of social and genetic inequality raises legitimate concerns. It is argued that inequalities produced (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  6. Michele Loi (2012). Introduction: Genetics and Justice. Ethical Perspectives 19 (1):1-10.
    Introduction to the Ethical Perspectives Theme Issue (19/1) on Genetics and Justice, with contributions by Greg Bognar, David Hunter, Michele Loi, Oliver Feeney, Vilhjálmur Arnason, Durnin et al.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  7. Andy Miah, Genetic Modification (Gm) in Sport: Legal Implications.
    Despite an emerging body of literature, an analysis of the legal issues arising from science and technology in sport remains largely unexplored.1 Perhaps one of the most common areas for the synthesis of these issues is found in regard to the use of drugs and other doping methods. However, there remains no theorising about legal issues arising from the possibility of using genetic technologies in sport. Nevertheless, an awareness of the imminent use of genetic technologies by athletes is beginning to (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  8. Russell Powell & Allen Buchanan (2011). Breaking Evolution's Chains: The Prospect of Deliberate Genetic Modification in Humans. Journal of Medicine and Philosophy 36 (1):6-27.
    Many philosophers invoke the "wisdom of nature" in arguing for varying degrees of caution in the development and use of genetic enhancement technologies. Because they view natural selection as akin to a master engineer that creates functionally and morally optimal design, these authors tend to regard genetic intervention with suspicion. In Part II, we examine and ultimately reject the evolutionary assumptions that underlie the master engineer analogy (MEA). By highlighting the constraints on ordinary unassisted evolution, we show how intentional genetic (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  9. John E. J. Rasko, Gabrielle O'Sullivan & Rachel A. Ankeny (eds.) (2006). The Ethics of Inheritable Genetic Modification: A Dividing Line? Cambridge University Press.
    Is inheritable genetic modification the new dividing line in gene therapy? The editors of this searching investigation, representing clinical medicine, public health and biomedical ethics, have established a distinguished team of scientists and scholars to address the issues from the perspectives of biological and social science, law and ethics, including an intriguing Foreword from Peter Singer. Their purpose is to consider how society might deal with the ethical concerns raised by inheritable genetic modification, and to re-examine prevailing views about whether (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  10. Ian M. Scott (2000). Green Symbolism in the Genetic Modification Debate. Journal of Agricultural and Environmental Ethics 13 (3-4):293-311.
    The character of the current controversy over geneticallymodified (GM) agriculture, typified by protesters' use of emotivesymbolism, has been largely inspired by the Green movement'snon-governmental organizations and political parties. This articleexplores the deeper philosophical and spiritual motivations of the Greenmovement, to inquire why it is implacably opposed to GM agriculture. TheGreen movement's anti-capitalism, exemplified by the hate-symbol statusof Monsanto as the company pioneering GM crops, is viewed within thewider context of alienation in the modern era. A complex of meanings isseen in (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  11. Robert Sparrow (2007). Procreative Beneficence, Obligation, and Eugenics. Genomics, Society and Policy 3 (3):43-59.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  12. Robert Streiffer (2010). Chimeras, Moral Status, and Public Policy: Implications of the Abortion Debate for Public Policy on Human/Nonhuman Chimera Research. Journal of Law, Medicine and Ethics 38 (2):238-250.
    Researchers are increasingly interested in creating chimeras by transplanting human embryonic stem cells (hESCs) into animals early in development. One concern is that such research could confer upon an animal the moral status of a normal human adult but then impermissibly fail to accord it the protections it merits in virtue of its enhanced moral status. Understanding the public policy implications of this ethical conclusion, though, is complicated by the fact that claims about moral status cannot play an unfettered role (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  13. C. Strong (2005). Reproductive Cloning Combined with Genetic Modification. Journal of Medical Ethics 31 (11):654-658.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  14. Henk Verhoog (1996). Genetic Modification of Animals. The Monist 79 (2):247-263.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  15. Sean A. Weaver & Michael C. Morris (2005). Risks Associated with Genetic Modification: – An Annotated Bibliography of Peer Reviewed Natural Science Publications. Journal of Agricultural and Environmental Ethics 18 (2).
    We present an annotated bibliography of peer reviewed scientific research highlighting the human health, animal welfare, and environmental risks associated with genetic modification. Risks associated with the expression of the transgenic material include concerns over resistance and non-target effects of crops expressing Bt toxins, consequences of herbicide use associated with genetically modified herbicide-tolerant plants, and transfer of gene expression from genetically modified crops through vertical and horizontal gene transfer. These risks are not connected to the technique of genetic modification as (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation